- WELL announces it has added 11 clinics to its Canadian Clinics
network since February 1, 2025. This
included 9 acquired clinics and 2 absorbed clinics. The combined
revenues from the added clinics is approximately $29 million with $2
million of EBITDA.
- WELL Canadian clinics grew organically at 24% for the full year
in 2024. This figure included 12% in same clinic revenue growth and
12% in organic absorption.
- WELL highlights that its pipeline of Canadian public sector
opportunities for technology services is now tracking almost 70
separate opportunities across all Canadian provinces and federally
worth more than $300M in deal
size(1). This figure reflects more than triple the size
of its public sector pipeline one year ago and represents the
largest public sector opportunity pipeline in the Company's
history.
- WELL's combined Canadian Clinic acquisition growth pipeline
currently includes 34 opportunities generating $450M in revenues.
VANCOUVER, BC, March 4,
2025 /CNW/ - WELL Health Technologies Corp. (TSX:
WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a
digital healthcare company focused on positively impacting health
outcomes by leveraging technology to empower healthcare
practitioners and their patients globally, is pleased to provide a
corporate update highlighting its recent momentum in Canadian
Clinics growth momentum and a record pipeline of Canadian public
sector business opportunities amidst a surge of "Buy Canadian"
sentiment.

Since February 1, 2025, WELL has
made significant strides in expanding its Canadian Clinics network,
adding 11 clinics through a combination of 9 acquired clinics and 2
absorbed clinics. These additions currently generate combined
revenues of approximately $29 million
and EBITDA of $2 million, further
strengthening WELL's position as a leader in the Canadian
healthcare sector and leaving room for further margin expansion as
the Company expects to apply its clinic transformation processes.
WELL's Canadian clinics demonstrated robust performance throughout
2024, achieving an organic growth rate of 24%. This figure includes
12% same-clinic revenue growth and 12% growth through organic
absorption.
Hamed Shahbazi, Founder and CEO
of WELL, stated, "The expansion of our Canadian Clinics Platform
and the remarkable growth in our public sector technology pipeline
are powerful indicators of WELL's ability to execute its growth
strategy effectively. The 'Buy Canadian' movement aligns perfectly
with our vision of strengthening the Canadian healthcare ecosystem.
We are well-positioned to seize these opportunities by delivering
innovative solutions that not only support healthcare practitioners
but also contribute to Canada's
economic resilience."
The Company's pipeline of Canadian public sector opportunities
for technology services has also seen substantial growth. WELL is
currently tracking almost 70 opportunities across all Canadian
provinces and federally, representing an estimated total contract
value of over $300 million. This
pipeline is the largest public sector opportunity pipeline in its
corporate history and represents more than triple the size of its
public sector pipeline one year ago. This growth underscores WELL's
strategic focus on capitalizing on emerging opportunities within
Canada's public sector and
reflects WELL's focus on building out a more robust product
portfolio not only internally but through its affiliates.
The recent surge in "Buy Canadian" sentiment presents a unique
opportunity for WELL. On February 1,
2025, Premier David Eby of
British Columbia announced a
directive to ban new procurement from U.S. companies in response to
the U.S. tariffs imposed by President Donald Trump. During a news conference in
Vancouver, Premier Eby outlined a
three-point plan to protect B.C. workers and businesses following
the implementation of 25% tariffs on Canadian goods (10% on energy)
effective February 4, 2025. His
directive urged the B.C. government and Crown corporations,
including ICBC, health services, and BC Hydro, to prioritize
Canadian goods and services, effectively blocking new procurement
contracts with U.S. companies. The Province of B.C. is one of
WELL's most important markets and relationships.
This sentiment has been echoed by leaders from other provinces
and at the federal level. Ontario
Premier Doug Ford and Quebec Premier François Legault have both
publicly supported prioritizing Canadian suppliers to strengthen
regional economies. Additionally, François-Philippe Champagne, Canada's Minister of Innovation, Science, and
Industry, has encouraged businesses across Canada to adopt a "Buy Canadian" approach and
announced federal initiatives to support companies transitioning to
domestic products and services. These measures emphasize the
long-term benefits of economic independence and resilience.
"I have never seen such strong interest from public sector
leaders in our products and services as we are experiencing right
now," said Shane Sabatino, Chief
People Officer and Head of Public Sector Partnerships at WELL. "Our
expanded capabilities, combined with a growing momentum to source
from Canadian companies, have created a unique opportunity for WELL
to make a significant impact. We are proud to collaborate with
public sector organizations across Canada, delivering innovative, homegrown
solutions that enhance healthcare delivery and support our national
economy."
On February 3, 2025, WELL
disclosed that it has no exposure to U.S. tariffs against Canadian
goods and any potential future tariffs imposed on services would
not harm the Company given that it currently does not offer its
healthcare software platform capabilities or care delivery
capabilities on a cross-border basis In addition, WELL has
significant exposure to the U.S. dollar as over 60% of its
revenues, Adj. EBITDA and cashflow is generated in U.S. dollars by
WELL's US based entities. While tariffs may contribute to a
challenging macroeconomic environment, WELL operates in the
healthcare sector, which is inherently defensive, recession proof
and insulated from much of the volatility affecting other
industries.
The Company's combined Canadian clinic acquisition growth
pipeline remains strong, with 34 potential opportunities under
evaluation, collectively generating $450million in revenues. This robust pipeline
reflects WELL's disciplined and strategic approach to expansion,
focusing on value-accretive opportunities that align with its
long-term growth strategy.
Footnotes:
1.
|
This quantum of sales
pipeline represents WELL's estimated total public sector
sales pipeline. It includes products and services that may be sold
by WELL, either sourced or developed directly by WELL or through
affiliated Canadian companies. The opportunities noted may
represent multi-year sales cycles and may or may not materialize at
all, with decisions potentially occurring in calendar year 2025
and/or beyond.
|
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL's mission is to tech-enable healthcare providers. We do
this by developing the best technologies, services, and support
available, which ensures healthcare providers are empowered to
positively impact patient outcomes. WELL's comprehensive healthcare
and digital platform includes extensive front and back-office
management software applications that help physicians run and
secure their practices. WELL's solutions enable more than 41,000
healthcare providers between the US and Canada and power the largest owned and
operated healthcare ecosystem in Canada with more than 200 clinics supporting
primary care, specialized care, and diagnostic services. In
the United States WELL's solutions
are focused on specialized markets such as the gastrointestinal
market, women's health, primary care, and mental health. WELL is
publicly traded on the Toronto Stock Exchange under the symbol
"WELL" and on the OTC Exchange under the symbol "WHTCF". To learn
more about the Company, please visit: www.well.company
This news release contains "Forward-Looking Information" within
the meaning of applicable Canadian securities laws, including,
without limitation: statements regarding the Company's growth
prospects, acquisition strategies, and the impact of governmental
policies on its business operations. Forward-Looking Information is
based on a number of estimates and assumptions are inherently
subject to significant business, economic and competitive
uncertainties and contingencies, many of which are beyond WELL's
control, which could cause actual results and events to differ
materially from those disclosed in this news release.
Forward-Looking Information generally can be identified by the use
of forward-looking words such as "may", "should", "will", "could",
"intend", "estimate", "plan", "anticipate", "expect", "believe",
"goal" or "continue", or the negative thereof or similar
variations. Forward-Looking Information involves known and unknown
risks, uncertainties and other factors that may cause future
results, performance, or achievements to be materially different
from the estimated future results, performance or achievements
expressed or implied by the Forward-Looking Information and the
Forward-Looking Information is not a guarantee of future results or
performance. WELL's comments expressed or implied by such
Forward-Looking Information are subject to a number of risks,
uncertainties, and conditions, many of which are outside of WELL's
control, and undue reliance should not be placed on such
information. Forward-Looking Information are qualified in their
entirety by inherent risks and uncertainties, including: the
performance of teh company's M&A growth program and/or the
company's public sector sales opportunities. WELL's ability to
capitalize on its public sector funnel and continue the organic or
inorganic growth that it has had in the past; direct and indirect
material adverse effects from adverse market conditions; risks
inherent in the primary healthcare sector in general; regulatory
and legislative changes; litigation risk; that future results may
vary from historical results; an inability to realize the expected
benefits and synergies of acquisitions; that market competition may
affect the business, results and financial condition of WELL and
other risk factors identified in documents filed by WELL under its
profile at www.sedar.com, including its most recent Annual
Information Form and its most recent Management, Discussion and
Analysis. Except as required by securities law, WELL does not
assume any obligation to update or revise any forward-looking
information, whether as a result of new information, events or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/well-health-provides-corporate-update-highlighting-canadian-clinics-growth-momentum-and-record-pipeline-of-canadian-public-sector-business-opportunities-amidst-surge-of-buy-canadian-sentiment-302391201.html
SOURCE WELL Health Technologies Corp.